News

Video

Interview with Piramal’s Peter DeYoung at DCAT

Key Learning Objectives

  • Demonstrate expertise in key areas of drug substance & drug product development and manufacturing with emphasis on APIs and ADCs
  • Piramal is expanding to meet current and future market demand
  • Piramal is a leader in integrated solutions with 15 sites in NA, EU and India

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Glenn Wright, President and CEO, PDA
© 2025 MJH Life Sciences

All rights reserved.